GH Research PLC

GHRS - CIK 0001855129

Market cap$1.29 B

Rank#2450

SEC filings186

GH Research PLC trades as GHRS and has a market capitalization of $1.29 B, making it the #2450 largest US-listed company by market value. This page tracks GH Research PLC through 186 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Total assets (latest FY)$288.23MFY 2025

Key statistics

Market cap: $1.29 B
Share price (derived)market cap / shares outstanding: $20.76
Shares outstandingas of 2025-12-31: 0.06B
R&D expenseFY 2025: $38.77M

Latest filings

Filing	Type	Filed
6-K	-	2026-05-21
EFFECT	-	2026-05-19
SCHEDULE 13G/A	-	2026-05-18
SCHEDULE 13G/A	-	2026-05-15
6-K	-	2026-05-14
F-3	-	2026-05-14
Prospectus supplement	424B5	2026-05-14
6-K	-	2026-05-14

Browse the full filing history (186 filings)

Similar companies

The largest companies sharing GH Research PLC's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T GHRS vs LLY

JNJJohnson & Johnson$573.98 B GHRS vs JNJ

ABBVAbbVie Inc.$399.47 B GHRS vs ABBV

MRKMerck & Co., Inc.$293.16 B GHRS vs MRK

AZNAstraZeneca PLC$286.27 B GHRS vs AZN

Frequently asked questions

What is GH Research PLC's market cap?

GH Research PLC (GHRS) has a market capitalization of $1.29 B as of 2026-06-10, ranking #2450 among US-listed companies.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.